Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F]fluorothymidine positron emission tomography: a pilot study. - Chen,W.; Delaloye,S.; Silverman,DH. (J Clin Oncol, 2007)